TRAIL administration down-modulated the acute systemic inflammatory response induced in a mouse model by muramyldipeptide or lipopolysaccharide

Cytokine

Volumn 60, Issue 1, 2012, Pages 43-46

  Marcuzzi, Annalisa ^a   Secchiero, Paola ^b   Crovella, Sergio ^a   Zauli, Giorgio ^a  

^a INSTITUTE FOR MATERNAL AND CHILD HEALTH IRCCS BURLO GAROFOLO   (Italy)

^b UNIVERSITY OF FERRARA   (Italy)

Author keywords

Acute inflammatory response; LPS; MDP; TRAIL

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 1ALPHA; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; MURAMYL DIPEPTIDE; RECOMBINANT TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; SERUM AMYLOID A;

ACUTE SYSTEMIC INFLAMMATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEVER; INFLAMMATION; LEUKOCYTE COUNT; MALE; MONONUCLEAR CELL; MOUSE; NONHUMAN; PERITONEAL CAVITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ACETYLMURAMYL-ALANYL-ISOGLUTAMINE; ACUTE DISEASE; ANIMALS; CHEMOKINE CCL2; CYTOKINES; DISEASE MODELS, ANIMAL; DOWN-REGULATION; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; IMMUNOASSAY; INFLAMMATION; INFLAMMATION MEDIATORS; INTERLEUKIN-1ALPHA; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, INBRED BALB C; RECOMBINANT PROTEINS; SERUM AMYLOID A PROTEIN; TNF-RELATED APOPTOSIS-INDUCING LIGAND;

BACTERIA (MICROORGANISMS); MUS;

EID: 84865418542     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2012.06.001     Document Type: Article

References (15)

1. Di Pietro R., Zauli G. Emerging non-apoptotic functions of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)/Apo2L. J Cell Physiol 2004, 201:331-334.
2. Secchiero P., Zauli G. Tumor-necrosis-factor-related apoptosis-inducing ligand and the regulation of hematopoiesis. Curr Opin Hematol 2008, 15:42-48.
3. Grosse-Wilde A., Voloshanenko O., Bailey S.L., Longton G.M., Schaefer U., Csernok A.I., et al. TRAIL-R deficiency in mice enhances lymph node metastasis without affecting primary tumor development. J Clin Invest 2008, 118:100-110.
4. Malin D., Chen F., Schiller C., Koblinski J., Cryns V.L. Enhanced metastasis suppression by targeting TRAIL receptor 2 in a murine model of triple-negative breast cancer. Clin Cancer Res 2011, 17:5005-5015.
5. Anel A., Martinez-Lostao L. APO2L/TRAIL: new insights in the treatment of autoimmune disorders. Recent Pat Inflamm Allergy Drug Discov 2011, 5:184-199.
6. Collison A., Foster P.S., Mattes J. Emerging role of tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) as a key regulator of inflammatory responses. Clin Exp Pharmacol Physiol 2009, 36:1049-1053.
7. McGrath E.E., Marriott H.M., Lawrie A., Francis S.E., Sabroe I., Renshaw S.A., et al. TNF-related apoptosis-inducing ligand (TRAIL) regulates inflammatory neutrophil apoptosis and enhances resolution of inflammation. J Leukocyte Biol 2011, 90:855-865.
8. Campioni D., Secchiero P., Corallini F., Melloni E., Capitani S., Lanza F., et al. Evidence for a role of TNF-related apoptosis-inducing ligand (TRAIL) in the anemia of myelodysplastic syndromes. Am J Pathol 2005, 166:557-563.
9. Secchiero P., Zerbinati C., di Iasio M.G., Melloni E., Tiribelli M., Grill V., et al. Synergistic cytotoxic activity of recombinant TRAIL plus the non-genotoxic activator of the p53 pathway nutlin-3 in acute myeloid leukemia cells. Curr Drug Metab 2007, 8:395-403.
10. Dinarello C.A., Elin R.J., Chedid L., Wolff S.M. The pyrogenicity of the synthetic adjuvant muramyl dipeptide and two structural analogues. J Infect Dis 1978, 138:760-767.
11. Rummel C., Gerstberger R., Roth J., Hübschle T. Parthenolide attenuates LPS-induced fever, circulating cytokines and markers of brain inflammation in rats. Cytokine 2011, 56:739-748.
12. Hussain S.P., Harris C.C. Inflammation and cancer: an ancient link with novel potentials. Int J Cancer 2007, 121:2373-2380.
13. Raoult D., Richet H. Nosocomial bacteraemia: the most neglected causes of death in Europe?. Clin Microbiol Infect 2011, 17:1123.
14. Lub-de Hooge M.N., de Jong S., Vermot-Desroches C., Tulleken J.E., de Vries E.G., Zijlstra J.G. Endotoxin increases plasma soluble tumor necrosis factor-related apoptosis-inducing ligand level mediated by the p38 mitogen-activated protein kinase signaling pathway. Shock 2004, 22:186-188.
15. Cziupka K., Busemann A., Partecke L.I., Pötschke C., Rath M., Traeger T., et al. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) improves the innate immune response and enhances survival in murine polymicrobial sepsis. Crit Care Med 2010, 38:2169-2174.